back to all Publications
Publication

Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia

Alimentary Pharmacology and Therapeutics, 2014
H. Perazzo, M. Munteanu, Y. Ngo, P. Lebray, N. Seurat, F. Rutka, M. Couteau, S. Jacqueminet P. Giral, D. Monneret, F. Imbert-Bismut, V. Ratziu, A. Hartemann-Huertier, C. Housset, T. Poynard & for the FLIP Consortium
PubMed: 25186086
DOI: 10.1111/apt.12946
Metabolic Disorders, Noninvasive Tests, Diabetes, Dyslipidemia
Publication

Comparative 10-Years Prognosis of Fibrotest (FT) and Liver Stiffness Measurement (LSM) by Transient Elastog-raphy (TE, Fibroscan) in 9364 Chronic Liver Diseases (CLD) Patients (Pts)

Abstract, 2015
Mona Munteanu, Yen Ngo, Hugo Perazzo, Pascal Lebray, Helmi Mkada, Olivier Deckmyn, Denis Monneret, Françoise Imbert-Bismut, Dominique Bonnefont-Rousselot, Vincent Thi-bault, Vlad Ratziu, Chantal Housset, Thierry Poynard
Noninvasive Tests, Liver Disease, Metabolic Diseases